Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.637.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.79EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XASEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.576EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.325EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.521EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.206EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used